Online Database of Chemicals from Around the World
Search |  Submit |  中文
Home >> Chemical Listing >> H >> 3a,4,5,6,7,7a-Hexahydro-exo-4,7-methanoinden-5-ol

3a,4,5,6,7,7a-Hexahydro-exo-4,7-methanoinden-5-ol
[CAS# 133-21-1]

List of Suppliers
Sichuan Zhongbang Technical Development Co., Ltd. China Inquire  
+86 (830) 258-5019
+86 18982761636
sales@zhongbangst.com
sheldon0chen@hotmail.com
QQ chat
Chemical manufacturer
chemBlink standard supplier since 2009
Achemica Switzerland Inquire  
+41 (24) 466-2929
contact@achemica.com
Chemical manufacturer since 2010
Complete supplier list of 3a,4,5,6,7,7a-Hexahydro-exo-4,7-methanoinden-5-ol
Identification
Name 3a,4,5,6,7,7a-Hexahydro-exo-4,7-methanoinden-5-ol
Synonyms Cydecanol; NSC 22463; 5-Hydroxy-3a,4,5,6,7,7a-hexahydro-4,7-methanoindene
Molecular Structure CAS # 133-21-1, 3a,4,5,6,7,7a-Hexahydro-exo-4,7-methanoinden-5-ol, Cydecanol, NSC 22463, 5-Hydroxy-3a,4,5,6,7,7a-hexahydro-4,7-methanoindene
Molecular Formula C10H14O
Molecular Weight 150.22
CAS Registry Number 133-21-1
EC Number 205-099-6
Properties
Solubility Sparingly soluble (12 g/L) (25 ºC), Calc.*
Density 1.157±0.06 g/cm3 (20 ºC 760 Torr), Calc.*
Melting point 97-98 ºC**
Boiling point 116-118 ºC (10 Torr)***
Refractive index 1.5065 (589.3 nm 20 ºC)**
Flash point 90.2±13.7 ºC, Calc.*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2014 ACD/Labs)
** GB 984828 1965.
*** GB 775298 1957.
Safety Data
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Acute toxicityAcute Tox.4H302
Eye irritationEye Irrit.2H319
Skin irritationSkin Irrit.2H315
Specific target organ toxicity - single exposureSTOT SE3H335
SDS Available
Market Analysis Reports
List of Reports Available for 3a,4,5,6,7,7a-Hexahydro-exo-4,7-methanoinden-5-ol
Related Products
N-[[(1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)amino]carbonyl]-4-(1-hydroxy-1-methylethyl)-2-furansulfonamide monosodium salt  Hexahydroindolizin-8-one  Hexahydro-1-[(5-iodo-1-naphthalenyl)sulfonyl]-1H-1,4-diazepine hydrochloride  cis-2,3,3a,4,7,7a-Hexahydro-1H-isoindole  2,3,3a,4,7,7a-Hexahydro-1H-isoindole  cis-Hexahydroisoindole hydrochloride  3,4,5,6,8,9-Hexahydro-2-isopropyl-4-oxo-7H-pyrimido[4,5-d]azepine-7-carboxylic acid tert-butyl ester  Hexahydro-1-(5-isoquinolinylsulfonyl)-1H-1,4-diazepine monohydrochloride hydrate (2:1)  (2aalpha,3beta,8beta,8aalpha)-1,2,2a,3,8,8a-Hexahydro-3,8-methanocyclobuta[b]naphthalene  Hexahydro-4,7-methanoindandimethanol  3a,4,5,6,7,7a-Hexahydro-4,7-methano-1H-inden-6-ol  3a,4,5,6,7,7a-Hexahydro-4,7-methano-1H-indenyl acrylate  (3aR,4S,7R,7aS)-rel-1,3,3a,4,7,7a-Hexahydro-4,7-methano-2H-isoindole-2-carboxylic acid 1,1-dimethylethyl ester  Hexahydro-6-hydroxy-1H-1,4-diazepine-1-carboxylic acid tert-butyl ester  5-[(Hexahydro-4-hydroxy-1H-1,4-diazepin-1-yl)sulfonyl]isoquinoline  (2S,3aR,5S,6S,6aS)-Hexahydro-6-hydroxy-4,4-dimethyl-2,5-methano-2H-furo[3,2-b]pyrrolium bromide (1:1)  (4aS-cis)-4,4a,5,6,7,8-Hexahydro-8-hydroxy-4a,8-dimethyl-2(3H)-naphthalenone  (3R,3aR,7S,8aS)-3,3a,4,7,8,8a-Hexahydro-6-(2-hydroxyethyl)-3,7-dimethyl-2H-cyclohepta[b]furan-2-one  (3aS,4S,6aR)-Hexahydro-N-(6-hydroxyhexyl)-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide  (3aS,4R,5S,6aR)-(+)-Hexahydro-5-hydroxy-4-(hydroxymethyl)-2H-cyclopenta[b]furan-2-one